133 related articles for article (PubMed ID: 8097953)
1. Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
Jones RB; Frodsham G; Dickinson K; Foster GA
Br J Pharmacol; 1993 Apr; 108(4):1111-6. PubMed ID: 8097953
[TBL] [Abstract][Full Text] [Related]
2. Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
Carceles MD; Aleixandre F; Fuente T; López-Vidal J; Laorden ML
Eur J Anaesthesiol; 2003 Mar; 20(3):205-11. PubMed ID: 12650491
[TBL] [Abstract][Full Text] [Related]
3. Failure of nitric oxide donors to alter arrhythmias induced by acute myocardial ischaemia or reperfusion in anaesthetized rats.
Barnes CS; Coker SJ
Br J Pharmacol; 1995 Jan; 114(2):349-56. PubMed ID: 7881734
[TBL] [Abstract][Full Text] [Related]
4. The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat.
Kane KA; Morcillo-Sanchez EJ; Parratt JR; Rodger IW; Shahid M
Br J Pharmacol; 1985 Jan; 84(1):139-45. PubMed ID: 2579698
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
6. Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat.
Carceles MD; Aleixandre F; Fuente T; López-Vidal J; Laorden ML
Can J Anaesth; 2001 May; 48(5):486-92. PubMed ID: 11394520
[TBL] [Abstract][Full Text] [Related]
7. Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.
Perreault CL; Hague NL; Loh E; Hunneyball IM; Sim MF; Morgan JP
Br J Pharmacol; 1992 Jul; 106(3):511-6. PubMed ID: 1324072
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyclic AMP-affecting agents on contractile reactivity of isolated mesenteric and renal resistance arteries of the rat.
Heesen BJ; De Mey JG
Br J Pharmacol; 1990 Dec; 101(4):859-64. PubMed ID: 1707706
[TBL] [Abstract][Full Text] [Related]
9. Synergistic action of cyclic GMP on catecholamine-induced chloride current in guinea-pig ventricular cells.
Ono K; Tareen FM; Yoshida A; Noma A
J Physiol; 1992; 453():647-61. PubMed ID: 1281506
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
Holbrook M; Coker SJ
Br J Pharmacol; 1989 Sep; 98(1):318-24. PubMed ID: 2478245
[TBL] [Abstract][Full Text] [Related]
11. Interaction of sildenafil with cAMP-mediated vasodilation in vivo.
Schalcher C; Schad K; Brunner-La Rocca HP; Schindler R; Oechslin E; Scharf C; Suetsch G; Bertel O; Kiowski W
Hypertension; 2002 Nov; 40(5):763-7. PubMed ID: 12411474
[TBL] [Abstract][Full Text] [Related]
12. Relationship between inotropic activity and phosphodiesterase inhibition for flosequinan and milrinone.
Weishaar RE; Kirker ML; Wallace AM; Ferraris VA; Britton LW; Sim MF
Eur J Pharmacol; 1993 Jun; 236(3):363-6. PubMed ID: 8395383
[TBL] [Abstract][Full Text] [Related]
13. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
15. The role of nitric oxide in modulating ischaemia-induced arrhythmias in rats.
Sun W; Wainwright CL
J Cardiovasc Pharmacol; 1997 Apr; 29(4):554-62. PubMed ID: 9156367
[TBL] [Abstract][Full Text] [Related]
16. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
Greenberg S; Touhey B; Paul J
Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
[TBL] [Abstract][Full Text] [Related]
17. Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes.
Kelso EJ; McDermott BJ; Silke B
J Cardiovasc Pharmacol; 1995 Mar; 25(3):376-86. PubMed ID: 7769801
[TBL] [Abstract][Full Text] [Related]
18. Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs.
Avendano CE; Billman GE
Eur J Pharmacol; 1994 Apr; 255(1-3):99-109. PubMed ID: 7517886
[TBL] [Abstract][Full Text] [Related]
19. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.
Toyoshima H; Nasa Y; Kohsaka Y; Isayama Y; Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624
[TBL] [Abstract][Full Text] [Related]
20. The genesis of arrhythmias during myocardial ischemia. Dissociation between changes in cyclic adenosine monophosphate and electrical instability in the rat.
Manning AS; Kinoshita K; Buschmans E; Coltart DJ; Hearse DJ
Circ Res; 1985 Nov; 57(5):668-75. PubMed ID: 2996804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
